Tate & Lyle Team Up With Solvay

Tate & Lyle has announced it has signed an agreement with Solvay to sell the ingredient Solactis® Galactofructose in bakery and other food and beverage applications in Europe (excluding Spain and Portugal), the Middle East and Africa.

Solactis Galactofructose is a non-digestible carbohydrate derived from milk. Following comprehensive clinical trials, Galactofructose has been shown to deliver wide ranging health benefits as a prebiotic ingredient which also regulates digestive transit at very low dosages. In addition scientific results suggest that it could be beneficial in stimulating mineral absorption, and helpful in managing weight.

Galactofructose was first employed as a food ingredient for infant milk formulas in the 1950’s and since the 1960’s has also been used in the pharmaceutical industry in North America, Asia and Europe. It is supported by more than 50 years of scientific research, 30 of them conducted by Solvay. The ingredient also holds a long history of use in Asia where it has been employed in dairy applications and in infant nutrition.

Tate & Lyle and Solvay will use Solactis Galactofructose to create a range of  ‘better for you’ food applications for and with customers. They will leverage synergies within Tate & Lyle’s existing food ingredients portfolio, including products such as Sta-lite Polydextrose and Promitor Resistant Starch.

Tate & Lyle will be showcasing Solactis Galactofructose as a part of its Enrich offering at Food Ingredients Europe 09. At stand Number 8M35, visitors will be able to taste a first series of innovative prototypes such as juice drinks and bakery items.